期刊文献+

表达人IL-17F重组腺病毒载体的构建及其表达产物的功能研究 被引量:3

Construction of recombinant adenovirus vector expressing hIL-17F and functional study of expressed IL-17 F
原文传递
导出
摘要 目的构建表达人白细胞介素IL-17F (hIL-17F)的重组腺病毒载体(Ad-hIL-17F),为进行hIL-17F基因表达抑制血管形成和抑瘤效应的研究奠定基础。方法以pUCm-T/hIL-17F重组质粒为模板PCR扩增hIL-17F,酶切连接到带有GFP标记的pAdTrack-CMV转移质粒上,PmeⅠ线性化重组质粒pAdTrack-CMV-hIL-17F,与腺病毒骨架质粒pAdEasy-1共转化BJ5183细菌,经同源重组,获得同源重组腺病毒质粒pAdEasy-1-pTrack-CMV-hIL-17F经PacⅠ线性化后转染QBI-293A细胞,收获Ad-hIL-17F,用RT-PCR和间接免疫荧光法鉴定人IL-17F基因表达。 MTT法检测hIL-17F基因表达对ECV304细胞的生长抑制作用, ELISA法检测人血管内皮生长因子( VEGF)和血管生成素( Ang-1)基因在293A细胞、ECV304细胞中的表达水平;实时定量RT-PCR检测Ad-hIL-17F对293A细胞中人VEGF转录的影响。结果测序显示hIL-17F序列正确,RT-PCR和间接免疫荧光法检测到了IL-17 F基因的表达。 Ad-hIL-17 F能显著抑制ECV304细胞的生长,抑制人VEGF和Ang-1基因在293 A细胞、ECV304细胞中的表达。结论成功构建和获得了hIL-17F的重组腺病毒载体(Ad-hIL-17F), Ad-hIL-17 F可通过下调VEGF和Ang-1的分泌而抑制血管形成。 Objective To construct a recombinant adenovirus vector ( Ad-hIL-17F) expressing human interleukin 17F (hIL-17F) and to investigate the effects of expressed hIL-17F on angiogenesis. Methods The hIL-17F fragments was amplified by PCR using pUCm-T/hIL-17F plasmids as templates and then cloned into pAdTrack-CMV transfer vector to form pAdTrack-CMV-hIL-17F.The pAdTrack-CMV-hIL-17F transfer vector was linearized with PmeI digestion and then transformed into competent BJ 5183 with pAdEasy-1 backbone vector for homologous recombination .Then it was linearized with PacI digestion and transfected into human embryonic kidney 293 (QBI-293A) cells to construct Ad-hIL-17F.RT-PCR analysis and indirect immunofluorescent assay (IFA) were performed to determine the expressions of hIL-17F.MTT assay was used to detect the inhibitory effects on cell growth of ECV 304 .The expressions of VEGF and Ang-1 in 293 A and ECV304 cells were measured by ELISA .The effects of Ad-hIL-17 F on the expressions of VEGF in 293A cells were analyzed by Real-Time PCR.Results The sequencing result verified that hIL-17F gene fragment was correctly inserted in the vector .The expressions of hIL-17F gene at mRNA and pro-tein levels were confirmed by RT-PCR and IFA.Ad-hIL-17F could significantly inhibit the growth of ECV304 cells and down-regulate the expressions of VEGF and Ang-1 in 293A and ECV304 cells.Conclu-sion Ad-hIL17F expressing hIL-17F was successfully constructed .The expressed hIL-17F could inhibit the angiogenesis through down-regulating the expressions of VEGF and Ang-1.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2013年第9期683-687,共5页 Chinese Journal of Microbiology and Immunology
关键词 IL-17F 腺病毒载体 构建 鉴定 hIL-17F Adenovirus vector Construction Identification
  • 相关文献

参考文献11

  • 1Starnes T, Robertson MJ, Sledge G, et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activat ed T cells and monocytes, regulates angiogenesis and en dothelial cell cytokine production.J Immunlol, 2001, 167(8): 41374140.
  • 2Moseley TA, Haudenschild DR, Rose L, et al. Inter leukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 2003, 14(2): 155-174.
  • 3谢宇锋,盛伟华,缪竞诚,杨吉成.人白细胞介素-17F基因克隆及在大肠杆菌中的表达[J].苏州大学学报(医学版),2005,25(6):981-985. 被引量:1
  • 4谢宇锋,盛伟华,缪竞诚,杨吉成.人IL-17F融合蛋白在E.coli中表达及其生物学活性研究[J].中国免疫学杂志,2006,22(12):1086-1091. 被引量:2
  • 5谢宇锋,盛伟华,缪竞诚,杨吉成.人IL-17F对裸鼠人肝癌移植瘤生长的影响[J].生物工程学报,2006,22(5):772-778. 被引量:3
  • 6Xie Y, Sheng W, XiangJ, et al. Interleukin-17F suppresses hep?atocarcinoma cell growth via inhibition of tumor angiogenesis. Cancer Invest, 2010, 28(6): 598-607.
  • 7Hurst SD, Mucha,muel T, Gorman DM, et al. New IL-17 family?memberspromote Thl or Th2 responses in the lung: in vivo func?tionof the novel cytokine IL-25.J Immunol, 2002; 169 (1) : 443- 453.
  • 8FolkmanJ, Klagsbrun M. Angiogenic factors. Science, 1987, 235 (4787) : 442447.
  • 9Carmeliet P,Jain RK. Angiogenesis in cancer and other diseases. Nature, 2000, 407 (6801) : 249-257.
  • 10Gasparini G. The rationale and future potential of angiogenesis in?hibitors in neoplasia. Drugs, 1999, 58 (1 ): 17 -38.

二级参考文献14

  • 1Starnes T, Robertson M, Sledge G, et al. Cutting edge:IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production[J]. J Immunlol, 2001,167:4137 - 4140.
  • 2Moseley TA, Haudenschild DR, Rose L, et al, Interleukin-17 family and IL-17 receptors [J ], Cytokine Growth Factor Rev, 2003, 14(2) : 155 - 174.
  • 3Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding[J]. EMBO J, 2001,20(19) :5332 - 5341.
  • 4Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases.Nature,2000,407:249-257
  • 5Gasparini G.The rationale and future potential of angiogenesis inhibitors in neoplasia.Drugs,1999,58:17-38
  • 6Gasparini G,Longo R,Toi M et al.Angiogenic inhibitors:a new therapeutic strategy in oncology.Nat Clin Pract Oncol,2005,2:562-577
  • 7Starnes T,Robertson M,Sledge G et al.Cutting edge:IL-17F,a novel cytokine selectively expressed in activated T cells and monocytes,regulates angiogenesis and endothelial cell cytokine production.J Immunol,2001,167:4137-4140
  • 8Hymowitz SG,Filvaroff EH,Yin JP et al.IL-17s adopt a cystine knot fold:structure and activity of a novel cytokine,IL-17F,and implications for receptor binding.EMBO J,2001,20:5332-5341
  • 9Tartour E,Fossiez F,Joyeux I et al.Interleukin 17,a T-cellderived cytokine,promotes tumorigenicity of human cervical tumors in nude mice.Cancer Res,1999,59:3698-3704
  • 10Scala G,Quinto I,Ruocco MR et al.Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.J Exp Med,1990,172:61-68

共引文献3

同被引文献19

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部